These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 1579114)

  • 1. Properties and use of botulinum toxin and other microbial neurotoxins in medicine.
    Schantz EJ; Johnson EA
    Microbiol Rev; 1992 Mar; 56(1):80-99. PubMed ID: 1579114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].
    Doussau F; Humeau Y; Vitiello F; Popoff MR; Poulain B
    J Soc Biol; 1999; 193(6):457-67. PubMed ID: 10783704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
    Simpson LL
    J Pharmacol Exp Ther; 1988 Jun; 245(3):867-72. PubMed ID: 2455038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADP-ribosylation of cerebrocortical synaptosomal proteins by cholera, pertussis and botulinum toxins.
    Ashton AC; Edwards K; Dolly JO
    Toxicon; 1990; 28(8):963-73. PubMed ID: 1981953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery from botulinum neurotoxin poisoning in vivo.
    Keller JE
    Neuroscience; 2006 May; 139(2):629-37. PubMed ID: 16490322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology.
    Callaway JE; Arezzo JC; Grethlein AJ
    Dis Mon; 2002 May; 48(5):367-83. PubMed ID: 12195266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of action and therapeutic uses of botulinum and tetanus neurotoxins].
    Popoff MR; Marvaud JC; Raffestin S
    Ann Pharm Fr; 2001 May; 59(3):176-90. PubMed ID: 11427819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanism of action of tetanus toxin and botulinum neurotoxins].
    Poulain B
    Pathol Biol (Paris); 1994 Feb; 42(2):173-82. PubMed ID: 7916455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum neurotoxin serotype D is poorly effective in humans: an in vivo electrophysiological study.
    Eleopra R; Montecucco C; Devigili G; Lettieri C; Rinaldo S; Verriello L; Pirazzini M; Caccin P; Rossetto O
    Clin Neurophysiol; 2013 May; 124(5):999-1004. PubMed ID: 23245668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum neurotoxin: the ugly duckling.
    Koussoulakos S
    Eur Neurol; 2009; 61(6):331-42. PubMed ID: 19365125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Structure and function of botulinum toxin].
    Fujii N
    Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins.
    Johnson EA
    Annu Rev Microbiol; 1999; 53():551-75. PubMed ID: 10547701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tables of Toxicity of Botulinum and Tetanus Neurotoxins.
    Rossetto O; Montecucco C
    Toxins (Basel); 2019 Nov; 11(12):. PubMed ID: 31771110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.
    Simpson LL; Coffield JA; Bakry N
    J Pharmacol Exp Ther; 1994 Apr; 269(1):256-62. PubMed ID: 8169833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
    Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action mechanisms of botulinum neurotoxins and tetanus neurotoxins].
    Deloye F; Doussau F; Poulain B
    C R Seances Soc Biol Fil; 1997; 191(3):433-50. PubMed ID: 9295967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use.
    Hambleton P
    J Neurol; 1992 Jan; 239(1):16-20. PubMed ID: 1311751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology.
    Callaway JE; Arezzo JC; Grethlein AJ
    Semin Cutan Med Surg; 2001 Jun; 20(2):127-36. PubMed ID: 11474745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New neurotoxins on the horizon.
    Freeman SR; Cohen JL
    Aesthet Surg J; 2008; 28(3):325-30. PubMed ID: 19083544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction between aminoquinolines and presynaptically acting neurotoxins.
    Simpson LL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):43-8. PubMed ID: 6283072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.